Wilbur B. Bowne MD
Associate Professor of Surgery, Drexel University School of Medicine
Join to View Full Profile
1100 Walnut StFl 5Philadelphia, PA 19107
Phone+1 215-955-6750
Fax+1 215-923-8222
Are you Dr. Bowne?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Wilbur Bowne, MD is a general surgeon in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and New York. He is an Associate Professor of Surgery at Drexel University School of Medicine.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Surgery, 1999 - 2002
Boston University Medical CenterResidency, Surgery, 1994 - 1999
State University of New York Downstate Medical Center College of MedicineClass of 1994
SUNY Upstate Medical UniversityClass of 1994
Certifications & Licensure
NY State Medical License 1996 - 2026
PA State Medical License 2010 - 2026
NJ State Medical License 2011 - 2025
American Board of Surgery Surgery
Publications & Presentations
PubMed
- Correlation of GNAS Mutational Status with Oncologic Outcomes in Patients with Resected Intraductal Papillary Mucinous Neoplasms.Julia Evans, Kylee Shivok, Hui Hsuan Chen, Eliyahu Gorgov, Wilbur B Bowne
Cancers. 2025-02-19 - Incisional hernia after major pancreatic resection: long term risk assessment from two distinct sources - A large multi-institutional network and a single high-volume ...Nitzan Zohar, Eliyahu Gorgov, Theresa P Yeo, Harish Lavu, Wilbur Bowne
HPB. 2024-12-01 - 1 citationsAssociation of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.Timothy Chao, Zi-Xuan Wang, Wilbur B Bowne, Clifford J Yudkoff, Ava Torjani
Archives of Pathology & Laboratory Medicine. 2024-12-01
Press Mentions
Dressed to Kill: Tailoring a Suit for Tumor-Penetrating Cancer MedicationsApril 8th, 2016
